Patients enrolled in this study with all eligibility criteria confirmed will be implanted with the TriCinch Coil System. This device offers a percutaneous treatment (access through the vein at the groin) to treat the leaking tricuspid valve.
CRITERIA LIST/ QUALIFICATIONS:
Moderate to severe functional tricuspid regurgitation 2+ to 4+
Left ventricular ejection fraction greater than or equal to 30%
Heart failure symptoms (such as fluid retention and severe edema, liver stasis)